SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

24.25p
   
  • Change Today:
      0.25p
  • 52 Week High: 25.00
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 231.98m
  • Volume: 1,273,246
  • Market Cap: £56.25m
  • Beta: 0.02

Latest ShareCast News

SkinBioTherapeutics shares jump on acquisition of topical cream maker

By Benjamin Chiou

Date: Friday 11 Oct 2024

(Sharecast News) - AIM-listed life sciences company SkinBioTherapeutics has announced the acquisition of Yorkshire-based health, hygiene and personal care products group Bio-Tech Solutions for £1.25m.

SkinBioTherapeutics reports positive results from testing with Croda

By Josh White

Date: Thursday 19 Sep 2024

(Sharecast News) - SkinBioTherapeutics announced on Thursday that final testing of its 'SkinBiotix' technology by Croda Beauty Care had yielded positive results, paving the way for commercialisation.

SkinBioTherapeutics secures £1.56m from new investors

By Josh White

Date: Friday 02 Aug 2024

(Sharecast News) - SkinBioTherapeutics announced on Friday that it has secured an investment of £1.56m on Friday, removing any uncertainty around its medium-term financing.

SkinBioTherapeutics reports better-than-expected... 29-Jul-2024 ShareCast
SkinBioTherapeutics reports positive interim acn... 27-Feb-2024 ShareCast
SkinBioTherapeutics finalises acquisition of Der... 26-Jan-2024 ShareCast
SkinBioTherapeutics launches new consumer study ... 25-Oct-2023 ShareCast
SkinBioTherapeutics gets France approval for pso... 15-Sep-2023 ShareCast
SkinBioTherapeutics selects probiotic blends for... 05-Sep-2023 ShareCast
SkinBioTherapeutics launching psoriasis suppleme... 21-Jun-2023 ShareCast
SkinBioTherapeutics pleased with progress on two... 10-May-2023 ShareCast
SkinBioTherapeutics reports progress with psoria... 17-Feb-2022 ShareCast
SkinBioTherapeutics commercially launches psoria... 29-Oct-2021 ShareCast
SkinBioTherapeutics confirms launch plans for ps... 30-Sep-2021 ShareCast
SkinBioTherapeutics launches research programme ... 08-Apr-2021 ShareCast
SkinBioTherapeutics confident in timelines amid ... 07-Jul-2020 ShareCast
SkinBioTherapeutics to develop psoriasis supplem... 19-Feb-2020 ShareCast
SkinBioTherapeutics strikes deal with chemicals ... 20-Nov-2019 ShareCast
SkinBioTherapeutics shuffles leadership as it dr... 04-Jul-2019 ShareCast
SkinBioTherapeutics pleased with first human stu... 08-Apr-2019 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 24.25p
Change Today 0.25p
% Change 1.04 %
52 Week High 25.00
52 Week Low 8.50
Volume 1,273,246
Shares Issued 231.98m
Market Cap £56.25m
Beta 0.02

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.8% below the market average70.8% below the market average70.8% below the market average70.8% below the market average70.8% below the market average
95.83% below the sector average95.83% below the sector average95.83% below the sector average95.83% below the sector average95.83% below the sector average
Price Trend
93.80% above the market average93.80% above the market average93.80% above the market average93.80% above the market average93.80% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
47.28% above the market average47.28% above the market average47.28% above the market average47.28% above the market average47.28% above the market average
54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average

SBTX Dividends

No dividends found

Trades for 31-Mar-2025

Time Volume / Share Price
16:30 100,000 @ 24.25p
16:47 200,000 @ 0.24p
16:28 10,000 @ 24.14p
16:27 20,000 @ 24.43p
16:26 5,000 @ 24.13p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page